Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: Potential implications for inflammation and plaque instability

Circulation

Volumn 101, Issue 12, 2000, Pages 1372-1378

  Schieffer, Bernhard ^a   Schieffer, Elisabeth ^a   Hilfiker Kleiner, Denise ^a   Hilfiker, Andres ^b   Kovanen, Petri T ^a   Kaartinen, Maija ^b   Nussberger, Jörg ^c   Harringer, Wolfgang ^a   Drexler, Helmut ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b WIHURI RESEARCH INSTITUTE   (Finland)

^c Medizinische Hochschule Hannover ^*

Author keywords

Angina; Angiotensin; Arteries; Interleukins; Myocardial infarction; Receptors

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CD68 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 6;

ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOOTH MUSCLE FIBER; UNSTABLE ANGINA PECTORIS;

EID: 0034724305     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.12.1372     Document Type: Article

References (44)

1. Libby P. Molecular bases of the acute coronary syndrome. Circulation. 1995;21 2844-2850.
2. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J. 1985;53:363-373.
3. Ross R. Pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
4. Van der Waal AC, Becker AE, Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:34-44.
5. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulation of T-cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 1986;6:131-138.
6. Kaartinen M, Penttilä A, Kovanen PT. Accumulation of mast cells in the shoulder region of human atheroma, the predilection site of atheromatous rupture. Circulation. 1994;90:1669-1678.
7. Galis ZS., Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark M, Amento E, Libby P. Cytokine-stimulated smooth muscle cells stimulate a complement of enzymes required for extracellular matrix digestion. Circ Res. 1994;75:181-189.
8. Kaartinen M, Penttilä A, Kovanen PT. Mast cells in the rupture-prone areas of human coronary atheromas produce and store TNFα. Circulation. 1996;94:2787-2792.
9. Biassuci L, Vitelli A, Liuzzo G, Altamura S, Caliguri G, Monaco C, Rebuzzi A, Ciliberto G, Maseri A. Elevated levels of interleukin-6 in unstable angina. Circulation. 1996;94:874-877.
10. Marx N, Neumann FJ, Ott I, Gawaz M, Koch W, Pikau T, Schömig A. Induction of cytokine expression in leucocytes in acute myocardial infarction. J Am Coll Cardiol. 1997;30:165-170.
11. Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin 6 family of cytokines and gp130. Blood. 1995;86:1243-1254.
12. Aldermann MH, Madhavan S, Ooi WL, Cohen H, Sealy JE, Laragh JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med. 1991; 324:1098-1104.
13. Cambien F, Costerousse O, Tirret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveilier D, Cambou JP, Luc G, Rakotovao R, Ducimetiere P, Sourbrier F, Alhenc-Gelas F. Plasma levels and gene polymorphism of angiotensin converting enzyme in relation to myocardial infarction. Circulation. 1994;90:669-676.
14. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arvelier D, Luc G, Bard JM, Bara R, Richard S, Tiret L, Amouyel P, Alhenc-Gelas F, Sourbrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
15. Pfeffer M, Braunwald E, Moye L, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltmann EM, Goldman S, Flaker GC, Klein M, Lamas G, Packer M, Rouleau J, Rutherford J, Wertheimer JH, Hawkins CM. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med. 1992;327: 669-677.
16. SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med. 1992;327:568-574.
17. Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation. 1995;92:1084-1088.
18. Aberg G, Ferrer P. Effects of captopril on atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharmacol. 1990;15(suppl I):S65-S72.
19. Daemen MJ, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 1991;68:450-456.
20. Powell JS, Clozel JP, Müller RK, Kühn H, Heft F, Hosning M. Inhibitors of angiotensin converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989;245:186-188.
21. Chobanian AV, Haudenschild CC, Nickerson C, Hope S. Trandolapril inhibits atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Hypertension. 1992;20:473-477.
22. Potter DD, Sobey CG, Tompkins PK, Rossen JD, Heistad DD. Evidence that macrophages in atherosclerotic lesions contain angiotensin II. Circulation. 1998;98:800-807.
23. Diet F, Pratt R, Berry GJ, Momose N, Gibbons G, Dzau VJ. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation. 1996;94:2756-2767.
24. Moreno PR, Falk E, Palaicos IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation. 1994;90:775-778.
25. Massenvandenbrink A, de Vries R, Danser AH. ACE but not chymase generates angiotensin II in close proximity to the AT1-receptor in human isolated coronary arteries. Circulation. 1998;98(suppl I):I-606. Abstract.
26. Loree HM, Kamm RD, Stringfellow RG, Lee RT. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res. 1992;71:850-858.
27. Ikeda U, Ikeda M, Seino Y, Takahashi M, Kasahara T, Kano S, Shimada K. Expression of intracellular adhesion molecule 1 in rat vascular smooth muscle cells by pro-inflammatory cytokines. Atherosclerosis. 1993;104:61-68.
28. Biswas P, Delfanti F, Mengozzi M, Cota M, Polentarutti N, Matnovani A, Lazzarin A, Sozzani S, Poli G. Interleukin 6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood. 1998;91:258-265.
29. Bacon K, Gearing A, Camp R. Induction of in-vitro human lymphocyte migration by interleukin 3, interleukin-4, and interleukin 6. Cytokine. 1990;2:100-105.
30. Hamanak R, Kohno K, Seguchi T, Okamura K, Morimoto T, Onon M, Ogata M, Kuwano M. Induction of low-density lipoprotein receptor and transcription factor SP-1 by tumor necrosis factor in human vascular endothelial cells. J Biol Chem. 1992;267:13160-13165.
31. Montavi A. The interplay between primary and secondary cytokines. Cytokines involved in the regulation of monocyte recruitment. Drugs. 1997;97(suppl I)15-23.
32. Boring L, Gosling J, Cleary M, Charo I. Decreased lesion formation in CCR2 -/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 1998;394:894-897.
33. Weinstock JV, Blum AM, Kassab JT. Angiotensin II is chemotactic for a T-cell subset which can express migration inhibitory factor activity in urine schistosomiasis mansoni. Cell Immunol. 1987;107: 180-187.
34. Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM, Callis GM, Quinn MT. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic smooth adventitia: enhancement by angiotensin II. Proc Natl Acad Sci USA. 1997;94:14483-14488.
35. Aviram M. Oxidative modification of low density lipoprotein and its relation to atherosclerosis. Isr J Med Sci. 1995;31:241-249.
36. Hernandez-Presa M, Bustos C, Ortego M, Tunon J, Renendo J, Ruiz-Ortega M, Egido J, Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-κB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation. 1997;95: 1532-1541.
37. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein and atherogenesis. J Clin Invest. 1991;88:1785-1792.
38. Keidar S. Kaplan M, Hofman A. Aviram M. Angiotensin II stimulates macrophage-mediated oxidation of low-density lipoproteins. Atherosclerosis. 1995;115:201-215.
39. Keidar S, Attias J, Smith J, Breslow J, Hayek T. The angiotensin II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice. Biochem Biophys Res Commun. 1997;236:622-625.
40. Erikson SV, Kjekhuis J, Eneroth P, Swedberg K. Neopterin, tumor necrosis factor C-reactive protein and prostaglandin E2 in patients with severe congestive heart failure treated with enalapril. Circulation. 1997;97(suppl I):I-322. Abstract.
41. Kokoonen JO, Saarinen J, Kovanen PT. Regulation of local angiotensin II formation in the human heart in the presence of interstitial fluid and of angiotensin-converting enzyme by Ang-(1-9) formed by heart carboxypeptidase A-like activity. Circulation. 1997;95:1455-1463.
42. Shanley TP, Foreback JL, Remick DG, Ullich TR, Kunkel SL, Ward PA. Regulatory effect of interleukin-6 in immunoglobulin G immune-complex-induced lung injury. Am J Pathol. 1997;151:193-203.
43. Nussberger J, Keller I, Waeber B, Brunner HR. Angiotensin II measurement with high affinity monoclonal antibodies. J Hypertens. 1988;6:S424-S425.
44. 1 receptor mediated signaling. Hypertension. 1996;27:476-480.